Electronic cigarettes for smoking cessation: a randomised controlled trial.

By C. Bullen, C. Howe, M. Laugesen, H. McRobbie, V. Parag, J. Williman, Natalie Walker. The Lancet, 2013

1,149 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017, positive): “Data from some observational studies and a randomized trial suggest that the efficacy of first-generation ecigarettes is similar to that of transdermal NRT patches [307] or NRT inhalers [308].”
Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Ann Am Thorac Soc 2014; 11(9): 1351-61.”
Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review (2014, background): “This explains why these products can be effective in reducing consumption of tobacco smoking [Bullen et al. 2013; Caponnetto et al. 2013b; Polosa et al. 2011] and are efficient as long-term substitutes of conventional cigarettes [Farsalinos et al.”